MSMarat Slessarev

Marat Slessarev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marat Slessarev has a total of 428 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethical guidance for randomized controlled trials of donor interventions in deceased organ donation: a scoping review of international guidelines, consensus statements, and expert recommendations

    by Nicholas B. Murphy, Hayden Nix, Henrietta Consolo, Frédérick D’ARagon, Jed Adam Gross, Dan Harvey, Alla Iansavitchene, Maureen Meade, Marat Slessarev, Matthew Weiss, et al.

  • Ethical and Methodological Features of Cluster Randomized Trials in Critical Care Settings: A Systematic Review

    by Eric Walser, Cory E. Goldstein, Julia F. Shaw, Hana Geres, Alla Iansavitchene, Kusum Menon, Simon Pupulin, Marat Slessarev, Monica Taljaard, Charles Weijer

    OBJECTIVES: Cluster randomized trials (CRTs) are useful for evaluating system-level interventions in critical care but raise complex ethical and methodological issues that are amplified in this setting. We aimed to describe ethical and methodological features of CRTs in critical care settings. DATA SOURCES: We performed a systematic literature search in MEDLINE and Embase. STUDY SELECTION: We included primary reports of CRTs in critical care settings published from 2004 to 2022 in English. DATA EXTRACTION: Two reviewers independently extracted data from each CRT, resolving any discrepancies by consensus. DATA SYNTHESIS: Among 102 CRTs, 77 CRTs (78%) reported trial registration and 101 CRTs (99%) reported research ethics committee review; five CRTs (5%) were exempted from review. Common designs were parallel-arm (48, 47%), two-period crossover (23, 23%), stepped-wedge (20, 20%), and multi-period crossover (8, 8%). A justification for using cluster randomization was provided in 47 CRTs (46%). Patients and caregivers were identified as research participants in 99 CRTs (97%). Of these, 74 CRTs (75%) reported on consent, which was most commonly waived consent (36, 49%). Healthcare providers were identified as research participants in 48 CRTs (47%). Of these, 11 CRTs (23%) reported on consent. Most (82, 80%) reported a sample size or power calculation, with 67 CRTs (82%) accounting for the intracluster correlation; 77 CRTs (76%) accounted for the intracluster correlation in the primary analysis. Among 85 CRTs with fewer than 40 clusters, 11 CRTs (13%) reported a small sample correction. CONCLUSIONS: Ethical and methodological shortcomings persist in CRTs. Enhanced reporting standards and adherence to established ethical frameworks, including the Ottawa Statement , are needed to ensure both scientific and ethical integrity in this essential design in critical care research.

  • Open Access

    Apnea Testing for Brain Death/Death by Neurologic Criteria in Adults: A Prospective Multicenter Observational Study Assessing the Relationship Between Methodology, Safety, and Duration

    by Sean Cuninghame, John Basmaji, James Duffin, Andrew Healey, Beth Paltser, Michelle Snyder-Salehi, Alexander Yoshiki, J. Gordon Boyd, Michael Hartwick, Karim Soliman, et al.

    IMPORTANCE: Apnea testing is an integral component of brain death (BD) assessments. The optimal method of Apnea Testing is currently not known. OBJECTIVES: To describe the current use of apnea test methods, and compare the effect of the chosen apnea test method (passive oxygenation, continuous positive airway pressure [CPAP], or exogenous C o 2 ) on safety and duration of apnea test in adult BD/death by neurologic criteria (DNC) organ donors. DESIGN: A prospective multicenter observational study. SETTING: Seventy-four ICUs in Ontario, Canada, who participate in organ donation practices. PATIENTS: All BD/DNC assessments in Ontario, Canada, from July 2023 to August 2024. INTERVENTIONS: None. MAIN OUTCOMES AND MEASURES: Outcomes included the rate of apnea test attempts, completions, and adverse events. We also measured the incidence of each method used and the duration of the apnea test. RESULTS: During the 1-year study period, a total of 368 BD/DNC assessments were performed, of which 361 (98%) attempted an apnea test. Of the 361 apnea tests attempted, 236 (65%) used passive oxygenation (tracheal insufflation), 103 (29%) used CPAP-based methods, and 22 (6%) used exogenous C o 2 . Nine tests were not completed: seven were terminated due to adverse events (all with passive oxygenation; five hypoxemia, two hemodynamic instability) and two due to observed respiratory effort. All adverse events occurred with the passive oxygenation method ( p = 0.20). No statistically significant differences were seen in apnea test duration between methods. The median test durations were 12 minutes (interquartile range [IQR], 10–17 min), 12 minutes (IQR, 8–15 min), and 15 minutes (IQR, 11–25 min) for passive oxygenation, positive pressure, and exogenous C o 2 , respectively. CONCLUSIONS AND RELEVANCE: In this large multicenter study, passive oxygenation was associated with a nonsignificant increase in adverse events compared with CPAP-based and exogenous C o 2 methods. Exogenous C o 2 did not shorten apnea test time. These findings support further investigation of CPAP-based methods as an alternative approach to apnea testing and refinement of C o 2 delivery parameters.


  • Open Access

    The Tip of the Iceberg: Pathway Biology Must Anchor the Next Generation of Critical Care Trials

    by Logan R. Van Nynatten, Douglas D. Fraser, Tristan Look-Hong, Marat Slessarev, John Basmaji

    Heterogeneity of treatment effect has yielded decades of negative critical care trials. Syndromic diagnoses like sepsis and acute respiratory distress syndrome mask distinct molecular programs that respond differently to the same intervention, and single biomarkers lack the resolution to capture this complexity. Recent evidence now demonstrates that each step of the enrichment pipeline, from real-time bedside endotyping to prospective endotype-matched therapy, is clinically operational. However, current approaches rely on limited biomarker panels that capture only surface-level biology. Pathway biology, examining coordinated dysregulation of molecular networks rather than isolated analytes, offers the deeper resolution needed to match patients to targeted therapies. We propose a translational pipeline integrating multiomics, pathway analysis, machine learning, and point-of-care assays to advance critical care toward pathway-focused predictive enrichment.


  • Open Access

    Supporting Informed Surrogate Decision-Making in Deceased Donor Intervention Research: Co-Creating Educational Materials With Families

    by Nicholas Murphy, Charles Weijer, Janice Msc Beitel, Mary Donaghy, Norma French, Christine Goddard, Jed Adam Jd Gross, Marat Slessarev

    Deceased donor intervention research aims to improve organ donation and transplantation outcomes, but its feasibility often depends on obtaining valid informed consent from surrogate decision makers during a difficult time for families in the ICU. Consent discussions may be complicated by grief, decisional burden, and the complexity of donor interventions, creating risks to comprehension, trust, and voluntariness. In this letter, we describe a collaborative model for co-creating consent and educational materials with deceased donors’ family members developed for a donor intervention trial in Canada. We outline our co-creation process and present five practical lessons learned, emphasizing trust, visual communication, standardization, the supportive role of educational tools, and iterative refinement. Our experience demonstrates that materials developed in partnership with donor families can enhance clarity, relevance, and sensitivity while supporting research coordinators. Our approach offers a scalable framework for improving informed consent processes and facilitating ethically robust donor intervention research.

  • Open Access

    Organ procurement organizations should develop policy regarding surrogate consent for normothermic regional perfusion

    by Nicholas B. Murphy, Matthew J. Weiss, Stephen Beed, Stéphanie Chartier-Plante, Prosanto Chaudhury, Jed Adam Gross, Andrew Healey, George Isac, Andreas Kramer, Marat Slessarev, et al.


  • Open Access

    Effect of Inhaled Volatile and IV Anesthetics on Biological Markers of Inflammation in Adult ICU and Thoracic Surgical Patients: A Systematic Review and Meta-Analysis

    by Soroush Rouhani, Sanchit Gupta, Hira Raheel, Aggie Duan Gao, Ciara Hanley, Xingshan Cao, Alla Iansavitchene, Brian H. Cuthbertson, Marat Slessarev, Ewan C. Goligher, et al.

    OBJECTIVES: Inhaled anesthetics may reduce alveolar and systemic inflammation in surgical and critically ill patients. This study aimed to perform a systematic review and meta-analysis comparing the effect of inhaled volatile and IV anesthetics on alveolar and plasma cytokines in patients with surgical or medical acute lung injury. DATA SOURCES: Medline, Embase, and Cochrane CENTRAL databases from 2000 to July 2021. STUDY SELECTION: Randomized control trials, prospective, and retrospective observational studies comparing inhaled volatile to IV anesthetics in ventilated adult patients with acute lung injury from lung resection or critical illness. DATA EXTRACTION: A systematic review and meta-analysis was performed. Primary outcome was alveolar inflammatory cytokines levels that were meta-analyzed using a random effects model. Secondary outcomes were plasma inflammatory cytokine levels, mortality, pulmonary complications, and duration of hospital and ICU stay. The quality of studies was assessed using the Cochrane Risk of Bias tool for randomized control trials and the Cochrane Risk Of Bias In Non-randomized Studies of Interventions tool for retrospective cohort studies. DATA SYNTHESIS: From 2522 screened studies, 28 (27 thoracic surgery and 1 ICU, n = 4175) were included. Meta-analysis of patients undergoing lung resection demonstrated lower levels of alveolar tumor necrosis factor-alpha (TNF-α) (standard mean difference 1.04; 95% CI, 0.32–1.77; p < 0.01; I 2 82%) and interleukin (IL)-6 (0.64; 95% CI, 0.52–0.75; I 2 0%; p < 0.01) at 1–2 hours in the inhaled anesthesia group, with no difference in other cytokines at various time points. The single ICU study demonstrated lower plasma TNF-α and IL-6 and alveolar TNF-α, IL-6, and IL-8 at 48 hours in patients sedated with sevoflurane compared with midazolam. Clinical outcomes were infrequently reported. CONCLUSIONS: Limited evidence suggests that inhaled anesthesia may reduce proinflammatory cytokines TNF-α and IL-6 during lung resection and critical illness. Further studies are needed to clarify its effects on biological markers and clinical outcomes.


  • Open Access

    The relationship between cessation of brain and systemic circulation after withdrawal of life-sustaining measures

    by Matthew Kolisnyk, Teneille E. Gofton, Loretta Norton, Derek B. Debicki, Nathan Scales, Amanda Van Beinum, Laura Hornby, Sam Shemie, Sonny Dhanani, Marat Slessarev


  • Coenrollment in a critical care trial: Characteristics and consequences

    by France Clarke, Lori Hand, Adam Deane, Nicole Zytaruk, Miranda Hardie, Yaseen Arabi, Abdulrahman Al-Fares, Diane Heels-Ansdell, William Dechert, Marlies Ostermann, et al.